Gary K. Lee
LYELGary K. Lee serves as officer: Chief Scientific Officer at Lyell Immunopharma, Inc. (LYEL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Gary K. Lee's Insider Trading at Lyell Immunopharma, Inc. (LYEL)
Buys
0 · $0.00
Sells
7 · $74.5K
Total Shares Bought
0
Total Shares Sold
3,941
Related Insiders
David Shook
officer: Chief Medical Officer
LYELSell · Sep 10, 2026
Stephen J. Hill
officer: Chief Operating Officer
LYELSell · Aug 25, 2026
Lynn Seely
President and CEO
LYELSell · Aug 25, 2026
Veronica Sanchez Bulis
VP, Corporate Controller
LYELSell · Aug 11, 2026
Innovative Cellular Therapeutics Holdings Ltd
10 percent owner
LYELSell · Jul 20, 2026
ARCH Venture Fund XIII, L.P.
10 percent owner
LYELBuy · Mar 9, 2026
ARCH Venture Partners IX, LLC
10 percent owner
LYELBuy · Mar 9, 2026